As shown in Figure 3C, When cells were immunoprecipitated with Keap1 and immunoblotted with Nrf-2 antibody, no obvious change was observed in Keap1/Nrf-2 interaction in GSCs and corresponding non-GSCs glioma cells. This evidence concerns the gene NFE2L2 and central nervous system cancer.